Literature DB >> 2064251

Risk factors associated with chronic obstructive lung disease.

M Higgins1.   

Abstract

Chronic obstructive lung disease (COLD) includes emphysema, chronic airways obstruction, and chronic bronchitis but not asthma. COLD mortality and morbidity rates are higher in men than women, in whites than blacks, and they increase with increasing age and with decreasing socioeconomic status. Death rates for COLD are approximately 10 times higher in cigarette smokers than in nonsmokers, and about 80% of COLD deaths in the United States are attributable to cigarette smoking. Among smokers, the quantity and duration of cigarette use are strongly related to mortality and morbidity, but susceptibility varies among individuals. Incidence of COLD is related inversely to pulmonary function and possibly to increased bronchial reactivity. Alpha 1-antiprotease deficiency, respiratory infections and symptoms, lean body build, and exposures to occupational hazards or air pollution have been associated with increased risks of COLD in epidemiologic and clinical studies. Susceptible individuals can reduce their risks of clinical disease by stopping smoking. Clinical trials are underway to determine whether bronchodilators reduce the rates of decline in pulmonary function.

Entities:  

Mesh:

Year:  1991        PMID: 2064251     DOI: 10.1111/j.1749-6632.1991.tb17001.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

Review 1.  Genetics and pulmonary medicine.10: Genetic epidemiology of pulmonary function.

Authors:  Y Chen
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

3.  Exposure to cold and draught, alcohol consumption, and the NS-phenotype are associated with chronic bronchitis: an epidemiological investigation of 3387 men aged 53-75 years: the Copenhagen Male Study.

Authors:  P Suadicani; H O Hein; H W Meyer; F Gyntelberg
Journal:  Occup Environ Med       Date:  2001-03       Impact factor: 4.402

4.  RAGE signaling during tobacco smoke-induced lung inflammation and potential therapeutic utility of SAGEs.

Authors:  Kelsey M Hirschi-Budge; Kary Y F Tsai; Katrina L Curtis; Gregg S Davis; Benjamin K Theurer; Anica M M Kruyer; Kyle W Homer; Ashley Chang; Pam M Van Ry; Juan A Arroyo; Paul R Reynolds
Journal:  BMC Pulm Med       Date:  2022-04-26       Impact factor: 3.320

5.  Metastable DNA methylation sites associated with longitudinal lung function decline and aging in humans: an epigenome-wide study in the NAS and KORA cohorts.

Authors:  Juan Jose Carmona; Richard T Barfield; Tommaso Panni; Jamaji C Nwanaji-Enwerem; Allan C Just; John N Hutchinson; Elena Colicino; Stefan Karrasch; Simone Wahl; Sonja Kunze; Nadereh Jafari; Yinan Zheng; Lifang Hou; Dawn L DeMeo; Augusto A Litonjua; Pantel S Vokonas; Annette Peters; Xihong Lin; Joel Schwartz; Holger Schulz; Andrea A Baccarelli
Journal:  Epigenetics       Date:  2018-10-21       Impact factor: 4.528

6.  Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients.

Authors:  T J Crowley; M J Macdonald; M I Walter
Journal:  Psychopharmacology (Berl)       Date:  1995-05       Impact factor: 4.530

7.  RAGE and tobacco smoke: insights into modeling chronic obstructive pulmonary disease.

Authors:  Adam B Robinson; Jeffrey A Stogsdill; Joshua B Lewis; Tyler T Wood; Paul R Reynolds
Journal:  Front Physiol       Date:  2012-07-25       Impact factor: 4.566

Review 8.  Carotenoids from Marine Microalgae: A Valuable Natural Source for the Prevention of Chronic Diseases.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Miranda Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-08-14       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.